The Data Is In: Canon Claims #1 Spot in Multiple Camera and Lens Categories
Canon Claims #1 Spot in Multiple Camera and Lens Categories
Melville, NY, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Canon U.S.A., Inc., a leader in digital imaging solutions is proud to announce that the EOS R6 Mark II was the top selling full-frame camera in the U.S. in 2024* and Canon has solidified the number one spot in multiple categories for cameras and lenses in the U.S. This includes:
#1 in Interchangeable Lens Cameras*
#1 in Mirrorless Cameras*
#1 in Full-Frame Mirrorless Cameras*
In addition to the above, Canon is also number one in full-frame cameras, lenses and mirrorless lenses*. Since the introduction of the EOS R system, Canon has continued its development of innovative products with cameras such as the EOS R1 and EOS R5 Mark II and lenses including the RF24mm F1.4 L VCM and RF50mm F1.4 L VCM. For the professional photographer on the sidelines of world-class sporting events, to portrait or wedding photographers looking to capture a moment of a lifetime and the family photographer who is documenting the hustle and bustle of everyday life - Canon cameras and lenses are a strong addition to the gear bags of any visual storyteller looking for high-quality images and video.
'Customers are Canon's greatest strength, and we strive to exceed their expectations – with hard work, quality products and innovation front and center, we've reached number one within the industry in the U.S.,' said Hiroto Kato, vice president, Business Planning & Strategy. 'At the core of Canon is our employees who have helped to achieve this great success while empowering our visual storytellers.'
To learn more about Canon's EOS R system visit: www.usa.canon.com/cameras/eos-r-system and to explore the world of Canon RF lenses, visit: www.usa.canon.com/pro/rf-lens-world
About Canon U.S.A. Inc.Canon U.S.A., Inc. is a leading provider of consumer, business-to-business, and industrial digital imaging solutions to the United States, Latin America, and the Caribbean markets. With approximately $29.4 billion in global revenue, its parent company, Canon Inc., as of 2024 has ranked in the top-10 for U.S. patents granted for 41 consecutive years†. Canon U.S.A. is dedicated to its Kyosei philosophy of social and environmental responsibility. To learn more about Canon, visit www.usa.canon.com and connect with us on LinkedIn at www.linkedin.com/company/canonusa.
† Based on patent counts issued by the United States Patent and Trademark Office and compiled by IFI CLAIMS Patent Services.
*Source: Circana, LLC, Retail Tracking Service, US, Detachable Lens and Lenses, Filters, Adaptors, and Caps Subcategories, Digital Lens Type(s): Digital SLR, Mirrorless Detachable Lens, Sensor Size: Full Frame, Lens Mount Type: Any, Imaging Accessory Type(s): Prime Lens, Zoom Lens, and Mirrorless Detachable Lens, Unit Sales by Brand, 12 Months Ending December 2024.
Attachment
Canon Claims #1 Spot in Multiple Camera and Lens Categories
CONTACT: Eloise Pisano Canon U.S.A., Inc. episano@cusa.canon.comSign in to access your portfolio
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Hamilton Spectator
30 minutes ago
- Hamilton Spectator
Morocco Strategic Minerals Launches Maiden Drill Program on Timarighine Property
MONTRÉAL, June 20, 2025 (GLOBE NEWSWIRE) — Morocco Strategic Minerals Corporation. (TSXV: MCC) ('Morocco Strategic Minerals' or the 'Corporation') is pleased to announce the commencement of its maiden drilling program on the Timarighine property, located in the eastern Anti-Atlas region of Morocco. This follows a successful initial exploration phase which confirmed the presence of high-grade copper mineralization and a robust structural framework with potential for scale. Phase 1 Highlights The initial phase of work at Timarighine focused on trench deepening, opening new exposures, geophysical surveying, and systematic channel and grab sampling. This exploration program led to the discovery of high-grade sulphide mineralization beginning at shallow depths (8–10 metres), previously masked by surface weathering. Channel and grab samples returned exceptional copper grades of up to 16.16% Cu*, with occurrences of native copper (figure 1) and occasionally silver values reaching up to 20 g/t Ag. Mineralization is also hosted by a strongly developed dyke stockwork system, indicating the presence of a broad mineralized envelope. Additionally, arsenopyrite concentrations of up to 5,079 ppm were identified, a mineral commonly associated with gold-bearing systems. These results further support the presence of a near-surface polymetallic system and reinforce the Corporation's drill targeting strategy for the upcoming drill program. * Grab and channel samples are selective by nature and are not necessarily representative of the mineralization hosted on the property Figure 1: High-grade sulphide mineralization encountered during Phase 1 of exploration at the Timarighine property, grading up to 16.16% copper (Cu). The samples also confirmed the presence of native copper. Planned Drilling Program The maiden drill campaign at Timarighine will consist of approximately 1,300 metres of diamond drilling (DDH) and 400 metres of reverse circulation (RC) drilling, designed to systematically evaluate the project's two most prominent mineralized structures as well as the surrounding stockwork zones. The diamond drill holes will primarily target the down-dip and along-strike extensions of the high-grade sulphide veins identified during Phase 1 trenching and sampling. These holes are designed to validate the extension of the mineralized zones at depth. In parallel, eight shallow RC holes (50 metres each) will be drilled to test the broader mineralized envelope between the known structures and toward the east, where geophysical and geological indicators suggest the potential for a disseminated or stockwork-style copper system. This two-pronged approach is designed to validate the Corporation's geological model while optimizing exploration efficiency and cost-effectiveness (figure 2). The program is fully permitted, fully funded and started on June 18, 2025. Figure 2: Planned diamond drilling (DDH) targeting the two main mineralized structures identified to date, where high-grade sulphide mineralization has been observed. The program also includes reverse circulation (RC) drilling designed to test the broader stockwork system and evaluate the potential extent of mineralization beyond the primary vein structures. About the Timarighine Property The Timarighine copper prospect is located in the Tazzarine rural commune within the Tazarine caïdat, Agdez district, Zagoura province, in Morocco's Drâa-Tafilalet region. Situated approximately 13 km northwest of Tazarine village, the property lies along the southern slopes of the Jbel Saghro in the eastern Anti-Atlas, an area renowned for copper mineralization, including the nearby Oumjrane deposit. Access to the site is available via national road R108, between Nkob and Tazarine, followed by a direct track to the Timarighine area. Covering approximately 64 km², the property comprises four contiguous exploration permits (3842563, 3842734, 3842735, and 3842736). The Timarighine property lies within an east-west trending depression on the southern front of the Precambrian-aged Saghro massif. Copper mineralization occurs along two parallel vein structures, known locally as 'iron cap' zones, marked by extensive alteration zones with hematite and goethite iron oxides. The mineralized structures are characterized by a shear system oriented NNE-SSW and feature local stockwork zones of brecciated carbonate-quartz-pyrite-chalcopyrite veinlets. The two main mineralized veins extend approximately 650 meters and 300 meters in length, with variable widths up to 5 meters. High-grade copper identified within these zones also hints at significant primary sulfide mineralization potential at depth, underscoring Timarighine's status as a high-value copper exploration target. About Morocco Strategic Minerals Morocco Strategic Minerals Inc. is a Canadian mineral exploration company focused on the acquisition, exploration, and, if warranted, development of natural resource properties of merit in Canada and Morocco. Qualified Person The technical and scientific information in this press release have been reviewed by Merouane Rachidi, Ph.D., an independent qualified person as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects ('NI 43-101'). Contact Information Pierre-Olivier Goulet Vice-President Corporate Development Email: pogoulet@ 1-450-821-5270 Guy Goulet President and CEO Email: ggoulet@ 1-514-294-7000 Forward-Looking Statements and Disclaimer Certain information contained herein may constitute 'forward-looking information' under Canadian securities legislation. Generally, forward-looking information can be identified using forward-looking terminology such as 'will be,' 'expected,' or variations of such words and phrases, or statements that certain actions, events, or results 'will' occur. Forward-looking statements, including statements relating to the intended use of the net proceeds from the Offering, are based on the Corporation's estimates and are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, level of activity, performance, or achievements of the Corporation to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Corporation will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws. Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release. Figures accompanying this announcement are available at:


Tom's Guide
43 minutes ago
- Tom's Guide
I've been shooting Fuji for 10 years, including the X-E4 — here's why I won't be buying the Fujifilm X-E5
I got my first Fujifilm in 2015, a Finepix something-or-other bridge camera. It kinda sucked in retrospect, but it was my first 'real' camera and sparked my interest in the Japanese brand. Since then, I've had a short rollick in the bushes with Canon, before embarking upon an outright steamy love affair with Sony. Then, a few years back, disillusioned with how photography was making me feel, I chucked in my 'do-everything' Sony A7 III and downsized to the Fujifilm X-E4. And oh boy, was it the best camera I could've bought. While the A7 III left me uninspired, the X-E4 made photography enjoyable again; it rekindled a love for the hobby that no camera has since lived up to. Unfortunately, mine was an ex-demo and developed a sensor issue, so I swapped to an X-Pro 3, leaving the X-E4 as the one that got away. Since then, I've owned an X-T4 and now an X-T5. I've also tested virtually every recent Fuji launch, including the Fujifilm X100VI, X-H2/S, X-S20, and even the medium format Fujifilm GFX100S II and Fujifilm GFX100 II. Same price, more camera. If, like me, you feel the X-E5 is a little overpriced, consider the Fujifilm X-T5, current holder of the "best APS-C" award on our roundup of the best mirrorless cameras. I own the X-T5 and trust me, it's a beaut! None of them, not even the X-Pro 3, has the spirit of the X-E4. While I love my X-T5, I still long for how the X-E line made me feel. Which is why I was so excited about the launch of the X-E5 — Could this be an opportunity to return to the glory days? Unfortunately, I think not. While I appreciate Fuji developing the X-E line, I'm not sure this fifth iteration is for me. To me, something about the magic of those cameras now feels lost. Here's why. Simply put, I feel Fuji has thrown too much at this camera. Part of the joy of the X-E4 was how much of a stripped back experience it proved to be. Short on physical controls, the X-E4 was a challenging camera to use at times, or at least it was when accustomed to professional cameras and the safety net of multiple Fn buttons. That made the X-E4 fun; it was an escape. It didn't have IBIS, or even a grip — that made it lightweight and plucky. It was arguably under-specced, but with purpose. It was a minimalist, simple street camera. I'm not sure the same can be said for the X-E5. I'll be reviewing the camera myself very soon, so I'll save my proper verdict until then, but from everything I've seen so far, it looks like Fuji has thrown way too much at the camera, spoiling that Spartan ethos. X-Es are lightweight street cameras that are easy to hold and keep steady. This may be an unpopular opinion, but I don't feel they need IBIS, a needless sacrifice to size and weight. Don't get me wrong, I know the value of and appreciate IBIS. I rely on it constantly in product photography either in the studio or on location, where I often need to drop my shutter. How often do I rely on it when shooting street, though? Virtually never. When am I gonna be shooting a moving, bustling street at ⅕ sec? Of course, as with almost every camera these days, the X-E5 is designed to be vlogger friendly. Hence the IBIS and the flip up screen (in fairness, also a feature on the X-E4). But wait a minute — isn't the Fujifilm X-M5 a vlogging camera? And the Fujifilm X-S20? Why does a third of the Fuji lineup need to be vlogging oriented? I know, it's all a bit 'old man shakes fist at clouds', but if the X-E5 is all about street photography and the experience and purity of shooting, as Fuji makes out, what does vlogging have to do with anything? 'Vlogging' seems to be the most overstated use case plaguing mirrorless cameras these days — how many people do you know who actually vlog? Then there's the film sim dial — essentially Fuji's 'look busy' trademark these days. Slap a film sim dial on it and make out it's revolutionary. Yawn. Surprise, surprise, Fujifilm has fitted the X-E5 with the 40.2MP X-Trans CMOS 5 HR APS-C sensor found in the Fujifilm X-H2 and Fujifilm X-T5. Oh, and the Fujifilm X-T50. And the Fujifilm X100VI. Does everything need a 40.2MP sensor? It's becoming a little cookie-cutter — why not just buy an X-T5? It'll cost you more or less the same. Now I know Fuji always reuses its sensors — everything had 26MP for a good while — but it now has two main X-Trans CMOS 5 variants: the 40.2MP HR and 26MP HS. The company recently equipped the X-S20 with the older X-Trans 4 26MP sensor, and fitted the Fujifilm X-H2S with the 26MP HS variant of the X-Trans 5 — so why not the X-E5? It would give fans a little variation, rather than just essentially picking from five versions of the same camera, all merely wearing different jackets. Besides, I'd argue that 40.2MP is simply not necessary in a street camera like this, or the X100VI. Again, don't get me wrong, I own the X-T5 and I appreciate the high resolution sensor when shooting product photography for work. But the X-E line is not the X-T line. I feel you lose some of the X-E line's spirit by stepping up to 40.2MP. The X-E4 was just fine with 26MP, which suited the more casual, fun, non-pixel-peeping mentality of the camera, not to mention the nostalgic look of the images. What's more, having the extra resolution (and therefore the ability to crop more aggressively) simply encourages users to shoot first and crop later, instead of taking the extra time to consider and frame your photos properly to begin with. It's just another element that chips away at the spirit of the X-E range. Apart from all the aforementioned, I would've liked to see Fuji fit the upgraded NP-W235 battery from the X-T5, rather than keeping X-E4's weakling NP-W126S. Fuji put a protruding grip on X-E5 anyway, so I wish it'd found space to house the larger battery inside. This would give users longer on the street without having to carry and change batteries — a genuinely useful upgrade for the target demographic. Most importantly, I'd have liked to see much, much better displays. Given this camera is priced similarly to the X-T5, I expected similar specification displays, namely the X-T5's tilting 1.84M-dot rear display and 3.69M-dot EVF. The X-E5 makes do with a 2.36M-dot EVF, and a puny 1.04M-dot rear LCD, which is lower resolution even than the X-E4, so we're going backwards. In a $1,699 camera, this is frankly inexcusable. It'll sell anyway, regardless of price — and Fuji knows that. It can charge whatever it wants. And that brings me onto price. On what planet should an X-E camera cost $1,699? Body only! That's literally a two-fold increase in price over the $849 X-E4 and the same price as the X-T5. Ask Fuji, and you'll probably hear some measly excuse about tariffs. Ask me, and I'll be a little more cynical. If there's anywhere near as much hype around this camera as the X100VI, it'll sell anyway, regardless of price — and Fuji knows that. It can charge whatever it wants. There are a few saving graces. There was no way this camera wasn't getting the X-Processor 5, but it's a great addition. There are new autofocus modes, which may be helpful in capturing that fleeting decisive moment on the street. This processor also brings Fuji's latest noise processing, allowing you to shoot at higher ISO without destroying files, and decreased power consumption over the X-Processor 4. The front grip is a solid addition, too. Fuji removed the X-E3's front grip on the X-E4, and despite its small stature, this caused problems when shooting at odd angles, especially in portrait orientation. I and many other users fitted aftermarket grips to the X-E4, which will no longer be necessary. Similarly, the rear of the camera sees the return of a thumb rest, which was't present on the X-E4 (again, the X-E3 had one). One of the first mods I made to the X-E4 was fitting a rear rest that slid into the hot shoe, giving extra grip when shooting in portrait. It's good to see a solution baked in here. Controversial, maybe, given online discourse, but I'm a fan of the new OVF simulation viewfinder mode and pared-back display mode. Like many Fuji fans, I'm not at all convinced of the continuation of the X-Pro line, and I think these modes are Fuji's way of merging the X-E and X-Pro ranges. Regardless, these features fit the X-E's experience-first ethos. And admittedly, I am very excited about the new 23mm pancake lens. I liked the X-E4's 27mm pancake in theory — it was super small and portable, complementing the nature of the camera. I just never really got on with its field of view, equating to around 40mm in full frame terms, which is a bit nothingy. Slightly too wide for street or portraits, but not wide enough for properly expansive scenes, like architecture. I'm glad Fuji has decided on a camp this time and gone wide. I'll be reviewing the X-E5 very soon, and my verdict will primarily be on the basis of how it performs as a standalone camera, which I'm sure will be excellent. Make no mistake, I don't think the X-E5 looks like a bad camera. The point of this ramble is that the X-E line has sentimental significance for me, like many others, which at its core lay in how the camera made me feel. That, in turn, stemmed from how well the X-E cameras lived up to a specific ethos: minimalist, engaging, fun. Same price, more camera. If, like me, you feel the X-E5 is a little overpriced, consider the Fujifilm X-T5, current holder of the "best APS-C" award on our roundup of the best mirrorless cameras. I own the X-T5 and trust me, it's a beaut! With the X-E5, I feel Fuji has eroded that ethos. And the reason, I think, is a lack of conviction. Fujifilm has tried to please too many people with the X-E5, and in turn has made it simply a cookie-cutter rehash of cameras that already exist, only worse, and ludicrously expensive. The X-E cameras are not vlogging cameras, so why try and sell the X-E5 to vloggers? The X-E cameras are street cameras, so why give in to a load of spec-swinging forum-dwellers complaining online about not having IBIS? Why fit it with the exact same running gear as four other cameras when we could've had variation, not to mention purity of purpose? I just don't get it, and I certainly won't buy it at that price. What I might just do, though, is go and pick up a used X-E4 before they skyrocket in value (again).


Business Wire
an hour ago
- Business Wire
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry
BUSINESS WIRE)-- ZIVO Bioscience, Inc. (OTCQB: ZIVO), a biotech and agtech R&D company engaged in the development of therapeutic and nutritional products derived from proprietary algal cultures, announces it has entered into a relationship with one of the world's leading animal health companies to advance ZIVO's novel immune-boosting compounds for use in multiple poultry market segments. The collaboration is expected to expand over time to address significant unmet needs in other livestock and companion animal species. Initially, ZIVO and its partner have executed two agreements that will govern independent studies designed to validate and expand the use of ZIVO's proprietary actives as immune-enhancing biologics to complement existing poultry vaccination strategies. The first agreement covers a 42-day study focused on coccidiosis, a parasitic disease that remains a major challenge to poultry producers worldwide. This challenge study is intended to confirm previously demonstrated effects of ZIVO's compound now co-administered with the collaborator's vaccine, and will include collecting tissue and plasma samples to evaluate performance parameters not previously examined. This trial will support the regulatory approval process of the USDA's Center for Veterinary Biologics, as well as to validate the commercial business case and lead to a commercial agreement. Under the second agreement, a study will assess ZIVO's compounds using a model of various viral diseases of significant consequence to the commercial poultry industry. The particular disease to be studied, which has no cure, is characterized by rapid onset and high mortality rates. The virus was selected for its well-established in vivo model, clear clinical endpoints and short study duration, while serving as a representative model for a range of other viral poultry diseases. This study was prompted by ZIVO's previously reported data showing reduced severity and spread of low-pathogenic avian influenza (LPAI) in treated birds. Positive outcomes from this trial will lead to a broader research agreement to pursue additional diseases. Applications for treating viruses represent a significant expansion of the therapeutic range and economic value of ZIVO's novel immune-boosting compounds. Both studies, to be fully funded by the collaborating company, will investigate several ZIVO product candidates for their ability to: Reduce the time between immunization and the onset of protective immunity, Protect birds during the vulnerable period between vaccination and immunity, Enhance the immune response following immunization, and Mitigate the immunosuppressive effects of diseases that leave birds susceptible to secondary infections. 'This collaboration supports our strategy to partner with a major animal health company that brings scientific expertise and R&D infrastructure to advance our innovations to global markets efficiently and at scale,' said John Payne, Chairman and Chief Executive Officer of ZIVO Bioscience. 'We are aligned with this company on the broad applicability of our immune-modulating technology and its potential to create a disruptive, non-antibiotic therapeutic platform. Adding ZIVO's therapeutic products to their portfolio would represent an entirely new market for our partner, and the significant prior work we've done provides high confidence for success.' About ZIVO Bioscience ZIVO Bioscience, Inc. is a research and development company with an intellectual property portfolio comprised of proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Please visit for more information. Forward Looking Statements Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including with respect to the Company's product candidate's potential to generate revenues and the expected timeframe for results of future studies. Words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates" and similar expressions or variations of such words are intended to identify forward-looking statements. Although ZIVO believes there is a reasonable basis for each forward-looking statement, we caution you that these statements are based on a combination of facts and factors currently known by us and our expectations of the future, about which we cannot be certain. Our actual future results may be materially different from what we expect due to factors largely outside our control, including risks that our strategic partnerships may not facilitate the commercialization or market acceptance of our products; risks that we will be unable to increase production sufficient to meet demand; risks that our products may not be ready for commercialization in a timely manner or at all; risks that our products will not perform as expected based on results of our preclinical and clinical trials; our ability to raise additional funds; uncertainties inherent in the development process of our products; changes in regulatory requirements or decisions of regulatory authorities; the size and growth potential of the markets for our products; the results of clinical trials; our ability to protect our intellectual property rights; and other risks, uncertainties and assumptions, including those described under the heading 'Risk Factors' in our filings with the Securities and Exchange Commission. These forward–looking statements speak only as of the date of this news release and ZIVO undertakes no obligation to revise or update any forward–looking statements for any reason, even if new information becomes available.